Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)
建设和创新:数字医疗技术和分析 (BIGDATA)
基本信息
- 批准号:10261325
- 负责人:
- 金额:$ 74.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:ARHGEF5 geneAlabamaBig DataBioinformaticsBiological Specimen BanksBiomedical ResearchBiometryBusinessesClinicalClinical DataClinical ImmunologyClinical InformaticsClinical InvestigatorClinical ResearchClinical SciencesClinical TrialsCollectionCommunitiesDataData AnalyticsData SourcesDevelopmentDevicesDiagnosisElectronic Health RecordEnvironmentFosteringFundingFutureGoalsHealth Information SystemHealth TechnologyHealth care facilityHealthcareImmune System DiseasesIndustryInformaticsInformation ServicesInstitutesInstitutionLightLinkMedicineMethodologyMethodsMissionMusculoskeletal DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient-Focused OutcomesPatientsPublic Health InformaticsRegistriesResearchResearch PersonnelResearch SupportResourcesRheumatismRheumatologyServicesTechnologyTrainingTranslational ResearchUniversitiesadvanced analyticsbasecare deliveryclinical centercommunity engagementcomparative effectivenesscomparative safetycomputer sciencedata warehousedesigndigitaldigital healthgenetic epidemiologyhealth datahealth economicshealth information technologyhealth planimplementation scienceimproved outcomeinnovationmHealthmembermobile computingmultidisciplinarypragmatic trialranpirnaseskin disordersmartphone Applicationsocial mediasuccesstooltranslational research programtranslational scientistwearable sensor technology
项目摘要
Project Summary
The Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB) has
long been recognized as an innovative institution advancing clinical and translational research in the study of
rheumatic, immunologic, musculoskeletal, and skin diseases. However, there is growing recognition that some
of the transformative, technologic advances in business and industry have not been effectively applied to
medicine, nor efficiently integrated within clinical environments to support state-of-the-art biomedical research
consistent with the NIAMS mission. The future of medicine, particularly clinical research, will see considerable
care delivery outside the confines of traditional health care facilities, using data captured by mobile technology
including Smartphone Apps and wearable biosensor devices. Our UAB team has developed expertise in many
domains of applied health information technology (HIT). Therefore we propose the Building and InteGrating
Digital heAlth Technology and Analytics (BIGDATA) Core Center for Clinical Research (CCCR) to harness
these technologies and make them available to support a broad base of investigators both within the institution,
and externally. We will combine Core capacities with our multiple, leveraged institutional resources to support
research relevant to the NIAMS mission. These include the UAB Center for Clinical and Translational Science
and its Partner Network that includes Auburn University (a collaborating institution in this application), the UAB
Informatics Institute, our Health System Information Services, electronic health record and data warehouse,
and collaborative institutional research centers whose members will make up a large portion of our user base.
Encompassing three distinct and synergistic cores (the Data Capture and Integration [DCI] Resource Core,
Methodologic, and Administrative), all aligned around the theme of mobile and digital health, informatics, real-
world data and advanced analytics, the BIGDATA CCCR will bring innovative HIT tools and methods to the
research community to effectively advance the NIAMS mission through the following Specific Aims: Aim
1: Promote outstanding, innovative, and synergistic rheumatologic and musculoskeletal disease-focused
research and expedite clinical, translational and informatics-related projects at the University of Alabama at
Birmingham through the utilization of our Methodologic Core composed of a diverse team with expertise in
biostatistics, bioinformatics, clinical informatics, statistical genetics, epidemiology, computer science, health
economics, and implementation science; Aim 2: To foster the development, refinement, and application of
existing and de novo digital technology data capture and analysis tools integrated with traditional data sources
to advance research in rheumatologic and musculoskeletal diseases through our Data Capture and
Integration Core (DCI); Aim 3: To promote the training of both junior and established clinical and translational
investigators in the current methods of clinical informatics and digital health tools applicable to the NIAMS
mission through diverse enrichment activities overseen by our Administrative Core.
项目概要
阿拉巴马大学伯明翰分校 (UAB) 临床免疫学和风湿病学部
长期以来被认为是推进临床和转化研究的创新机构
风湿病、免疫病、肌肉骨骼病和皮肤病。然而,人们越来越认识到,一些
商业和工业领域的变革性技术进步尚未有效地应用于
医学,也不能有效地集成到临床环境中以支持最先进的生物医学研究
与 NIAMS 的使命一致。医学的未来,特别是临床研究,将会有相当大的发展
使用移动技术捕获的数据,在传统医疗机构的范围之外提供医疗服务
包括智能手机应用程序和可穿戴生物传感器设备。我们的 UAB 团队在许多领域积累了专业知识
应用健康信息技术(HIT)领域。因此我们提出构建和集成
数字医疗技术与分析 (BIGDATA) 临床研究核心中心 (CCCR) 利用
这些技术并使其可用于支持机构内广泛的调查人员,
和外部。我们将把核心能力与我们的多种杠杆机构资源相结合,以支持
与 NIAMS 任务相关的研究。其中包括 UAB 临床和转化科学中心
及其合作伙伴网络,包括奥本大学(本申请中的合作机构)、UAB
信息学研究所、我们的卫生系统信息服务、电子健康记录和数据仓库,
以及合作机构研究中心,其成员将构成我们用户群的很大一部分。
包含三个不同且协同的核心(数据捕获和集成 [DCI] 资源核心、
方法论和管理),所有这些都围绕移动和数字健康、信息学、现实的主题
世界数据和高级分析,BIGDATA CCCR 将为世界带来创新的 HIT 工具和方法
研究界通过以下具体目标有效推进 NIAMS 使命:
1:促进以风湿病和肌肉骨骼疾病为重点的优秀、创新、协同
在阿拉巴马大学研究并加速临床、转化和信息学相关项目
伯明翰通过利用我们的方法核心,该核心由具有专业知识的多元化团队组成
生物统计学、生物信息学、临床信息学、统计遗传学、流行病学、计算机科学、健康
经济学和实施科学;目标2:促进开发、完善和应用
与传统数据源集成的现有和从头数字技术数据捕获和分析工具
通过我们的数据采集和技术推进风湿病和肌肉骨骼疾病的研究
集成核心(DCI);目标 3:促进初级和成熟临床和转化人员的培训
研究人员了解适用于 NIAMS 的当前临床信息学方法和数字健康工具
通过由我们的行政核心监督的各种丰富活动来完成使命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY R. CURTIS其他文献
JEFFREY R. CURTIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY R. CURTIS', 18)}}的其他基金
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)
建设和创新:数字医疗技术和分析 (BIGDATA)
- 批准号:
10704045 - 财政年份:2020
- 资助金额:
$ 74.84万 - 项目类别:
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)
建设和创新:数字医疗技术和分析 (BIGDATA)
- 批准号:
10468951 - 财政年份:2020
- 资助金额:
$ 74.84万 - 项目类别:
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
带状疱疹活疫苗对抗 TNF 使用者的安全性和有效性(VERVE 试验)
- 批准号:
8850397 - 财政年份:2014
- 资助金额:
$ 74.84万 - 项目类别:
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
带状疱疹活疫苗对抗 TNF 使用者的安全性和有效性(VERVE 试验)
- 批准号:
8629238 - 财政年份:2014
- 资助金额:
$ 74.84万 - 项目类别:
Facilitating Treat-to-Target Using Novel Health Technology with Decision support
使用新颖的健康技术和决策支持促进治疗达到目标
- 批准号:
8475813 - 财政年份:2013
- 资助金额:
$ 74.84万 - 项目类别:
The TAKEOFF Trial: Clinical Trial Planning Grant
TAKEOFF 试验:临床试验计划补助金
- 批准号:
8031114 - 财政年份:2011
- 资助金额:
$ 74.84万 - 项目类别:
Longitudinal Comparative Effectiveness & Safety of Biologics in Autoimmunity
纵向比较有效性
- 批准号:
8531880 - 财政年份:2009
- 资助金额:
$ 74.84万 - 项目类别:
相似海外基金
Harnessing big data to arrest the HIV/HCV/opioid syndemic in the rural and urban South
利用大数据遏制南方农村和城市的艾滋病毒/丙型肝炎/阿片类药物流行病
- 批准号:
10696612 - 财政年份:2023
- 资助金额:
$ 74.84万 - 项目类别:
A type 2 hybrid effectiveness-implementation trial to evaluate a population health combination intervention to meet HIV testing, linkage, and viral suppression goals in coastal Alabama
一项 2 型混合有效性实施试验,旨在评估人口健康组合干预措施,以实现阿拉巴马州沿海地区的 HIV 检测、关联和病毒抑制目标
- 批准号:
10461324 - 财政年份:2022
- 资助金额:
$ 74.84万 - 项目类别:
A type 2 hybrid effectiveness-implementation trial to evaluate a population health combination intervention to meet HIV testing, linkage, and viral suppression goals in coastal Alabama
一项 2 型混合有效性实施试验,旨在评估人口健康组合干预措施,以实现阿拉巴马州沿海地区的 HIV 检测、关联和病毒抑制目标
- 批准号:
10653984 - 财政年份:2022
- 资助金额:
$ 74.84万 - 项目类别:
Building and InnovatinG: Digital heAlth Technology and Analytics (BIGDATA)
建设和创新:数字医疗技术和分析 (BIGDATA)
- 批准号:
10704045 - 财政年份:2020
- 资助金额:
$ 74.84万 - 项目类别: